Related Experiment Video

Updated: May 5, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.8K

Erratum: Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas

Natalie M Meléndez-Vázquez, Teresa T Nguyen, Xuejun Fan

    Molecular Therapy. Oncology
    |April 29, 2024
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1016/j.omton.2024.200787.].

    More Related Videos

    Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
    05:45

    Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

    Published on: July 31, 2017

    9.6K
    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
    09:17

    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

    Published on: September 13, 2022

    2.3K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
    12:52

    Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

    Published on: November 28, 2015

    15.8K
    Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
    05:45

    Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

    Published on: July 31, 2017

    9.6K
    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
    09:17

    Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

    Published on: September 13, 2022

    2.3K

    Related Concept Videos

    The Oral Microbiota01:27

    The Oral Microbiota

    90
    The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
    90
    Gut-Brain Axis01:22

    Gut-Brain Axis

    222
    The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
    222

    Articles linked to this work by shared authors, journal, and citation graph.

    SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target.

    International journal of molecular sciences·2026

    Gut microbiota variation in admixed Hispanic populations with polyendocrine metabolic ovarian syndrome.

    Frontiers in endocrinology·2026

    Community Dynamics in a Changing World: highlights from the 1st Puerto Rico & Caribbean Microbiome Symposium and vision for a new microbiome hub.

    Sustainable microbiology·2026

    Behavioral and Microbial Profiling of the Bethylid Wasp Cephalonomia stephanoderis for Biocontrol of the Coffee Berry Borer.

    Biological control : theory and applications in pest management·2026

    Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis.

    Journal for immunotherapy of cancer·2026

    Cervicovaginal Microbiota and Biogenic Amine Metabolic Shifts in HPV-Associated Cervical Disease.

    Cancers·2026

    FOXM1 drives cisplatin resistance in ovarian cancer through STIM1-mediated SOCE and STAT1 activation.

    Molecular therapy. Oncology·2026

    Engineering "off-the-shelf" TCR-T cells: A transient mRNA platform for balanced alloreactivity and functionality.

    Molecular therapy. Oncology·2026

    Preclinical evaluation of triple-mutated oncolytic herpes virus expressing fusion-type interleukin 12 for malignant melanoma.

    Molecular therapy. Oncology·2026

    A p53R273H-selective bispecific T cell engager: Computational design and functional validation.

    Molecular therapy. Oncology·2026

    Erratum: AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

    Molecular therapy. Oncology·2026

    Erratum: Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8+ T cells in treated muscle and limits tumor infiltration.

    Molecular therapy. Oncology·2026

    Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

    Frontiers in oncology·2026

    Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

    Frontiers in medicine·2026

    Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

    Frontiers in immunology·2026

    Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

    Research (Washington, D.C.)·2026

    Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

    Frontiers in medical technology·2026

    Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us